SPS

Clinical trials for SPS explained in plain language.

Never miss a new study

Get alerted when new SPS trials appear

Sign up with your email to follow new studies for SPS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Engineered immune cells target root cause of debilitating neurological disease

Disease control Ongoing

This study is testing whether a therapy called KYV-101 can help people with Stiff Person Syndrome (SPS) who haven't improved with other treatments. KYV-101 uses a patient's own immune cells, which are modified in a lab to find and remove the specific B cells thought to drive the …

Matched conditions: SPS

Phase: PHASE2 • Sponsor: Kyverna Therapeutics • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

SPS

Get alerted when new SPS trials appear

Engineered immune cells target root cause of debilitating neurological disease